ReviewAntibodies (Basel, Switzerland)2025

Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges.

Yuan Zong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.